Isomorphic Labs website screenshot

Isomorphic Labs

Isomorphic Labs is a London-based AI-first drug discovery company spun out of Google DeepMind in 2021 and operating as an Alphabet subsidiary. Founded and led by Sir Demis Hassabis, the company applies frontier AI — including derivatives of the Nobel-winning AlphaFold system and its proprietary Unified Drug Design Engine — to accelerate the design of small-molecule and biologic therapeutics across oncology, immunology, and other therapeutic areas. The Drug Design Engine is positioned as a target- and disease-agnostic, multi-modality platform that combines predictive and generative models with a curated proprietary life-science "Dataverse" and large-scale GPU infrastructure. Isomorphic Labs monetises through strategic pharmaceutical research collaborations — disclosed deals include Novartis (January 2024, expanded February 2025), Eli Lilly, and Johnson & Johnson (January 2026) — and through its own internal therapeutic pipeline. The company closed a $600M external Series B investment round in March 2025. Isomorphic Labs does not operate a public developer API, SDK, or open-source release of its Drug Design Engine; external researcher access to AlphaFold-family models is provided separately by Google DeepMind via the free AlphaFold Server (alphafoldserver.com) for non-commercial use, and via the open-source AlphaFold 3 inference code released by DeepMind. The Isomorphic Labs GitHub organisation hosts only a small number of forks of internal Kubernetes and configuration-management tooling.

Isomorphic Labs is profiled on the APIs.io network. Tagged areas include Artificial Intelligence, Drug Discovery, Pharmaceuticals, Life Sciences, and Biotechnology.

Isomorphic Labs’ developer surface includes engineering blog and 17 more developer resources.

4.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0
0 APIs
Artificial IntelligenceDrug DiscoveryPharmaceuticalsLife SciencesBiotechnologyComputational BiologyProtein StructureAlphaFoldGenerative AIFoundation ModelsSmall MoleculesBiologicsOncologyImmunologyAlphabetDeepMind

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/isomorphic-labs: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Isomorphic Labs Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Build 2

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 3

Status, limits, changes, and where to get help

Company 7

The organization behind the API

Scroll for all 7

Other 5

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: isomorphic-labs
name: Isomorphic Labs
description: Isomorphic Labs is a London-based AI-first drug discovery company spun out of Google DeepMind in 2021 and operating
  as an Alphabet subsidiary. Founded and led by Sir Demis Hassabis, the company applies frontier AI — including derivatives
  of the Nobel-winning AlphaFold system and its proprietary Unified Drug Design Engine — to accelerate the design of small-molecule
  and biologic therapeutics across oncology, immunology, and other therapeutic areas. The Drug Design Engine is positioned
  as a target- and disease-agnostic, multi-modality platform that combines predictive and generative models with a curated
  proprietary life-science "Dataverse" and large-scale GPU infrastructure. Isomorphic Labs monetises through strategic pharmaceutical
  research collaborations — disclosed deals include Novartis (January 2024, expanded February 2025), Eli Lilly, and Johnson
  & Johnson (January 2026) — and through its own internal therapeutic pipeline. The company closed a $600M external Series
  B investment round in March 2025. Isomorphic Labs does not operate a public developer API, SDK, or open-source release of
  its Drug Design Engine; external researcher access to AlphaFold-family models is provided separately by Google DeepMind
  via the free AlphaFold Server (alphafoldserver.com) for non-commercial use, and via the open-source AlphaFold 3 inference
  code released by DeepMind. The Isomorphic Labs GitHub organisation hosts only a small number of forks of internal Kubernetes
  and configuration-management tooling.
type: Index
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
position: Producing
access: 3rd-Party
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/isomorphic-labs.png
tags:
- Artificial Intelligence
- Drug Discovery
- Pharmaceuticals
- Life Sciences
- Biotechnology
- Computational Biology
- Protein Structure
- AlphaFold
- Generative AI
- Foundation Models
- Small Molecules
- Biologics
- Oncology
- Immunology
- Alphabet
- DeepMind
tags_raw:
- Artificial Intelligence
- Drug Discovery
- Pharmaceutical
- Life Sciences
- Biotechnology
- Computational Biology
- Protein Structure
- AlphaFold
- Generative AI
- Foundation Models
- Small Molecules
- Biologics
- Oncology
- Immunology
- Alphabet
- DeepMind
url: https://raw.githubusercontent.com/api-evangelist/isomorphic-labs/refs/heads/main/apis.yml
created: '2026-05-24'
modified: '2026-05-24'
specificationVersion: '0.23'
apis: []
common:
- type: DomainSecurity
  url: security/isomorphic-labs-domain-security.yml
- type: Website
  url: https://www.isomorphiclabs.com
- type: OurTech
  url: https://www.isomorphiclabs.com/our-tech
- type: Partnerships
  url: https://www.isomorphiclabs.com/partnerships
- type: OurTeam
  url: https://www.isomorphiclabs.com/our-team
- type: LifeAtIso
  url: https://www.isomorphiclabs.com/life-at-iso
- type: Careers
  url: https://www.isomorphiclabs.com/work-with-us
- type: JobOpenings
  url: https://www.isomorphiclabs.com/job-openings
- type: Newsroom
  url: https://www.isomorphiclabs.com/news
- type: AlphaFoldServer
  url: https://alphafoldserver.com
- type: AlphaFold3Code
  url: https://github.com/google-deepmind/alphafold3
- type: GitHubOrganization
  url: https://github.com/isomorphiclabs
- type: Twitter
  url: https://twitter.com/IsomorphicLabs
- type: LinkedIn
  url: https://www.linkedin.com/company/isomorphic-labs
- type: PressContact
  url: mailto:press@isomorphiclabs.com
- type: PartneringContact
  url: mailto:partnering@isomorphiclabs.com
- type: GeneralContact
  url: mailto:connecting@isomorphiclabs.com
- url: https://www.isomorphiclabs.com/news
  type: Blog
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/isomorphic-labs"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/isomorphic-labs/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/isomorphic-labs/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.